GlaxoSmithKline Pharmaceuticals

BSE : 500660 | NSE : GLAXO
Industry : Pharma MNC | ISIN : INE159A01016 | FreeFloat : 24.24% | FnO : No | LotSize : N/A
Intellectual Capital (IC)17,159.17
Net Worth (NW)1,619.46
Intrinsic Worth (IW)18,778.63
Market Cap (MC)22,340.42
Economic Value Added104.66
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)91.38%
IC Gross Margin (EBITDA/IC)5.76%
IC Net Margin (NPT/IC)8.68%
Knowledge Turnover (Sales/IC)0.20
Market to Intrinsic Value (MC/IW)1.19
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 1,108.50Rs. 1,318.75
20 Mar 2023 ---- Rs. 1,282.60
-4.80     -0.37%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 1,287.13SellAvoid
KB > 50% : Yes50 DMA : Rs. 1,282.70
0 < M2IV < 1 : NoVol-Price trend : Falling
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
775.80
791.62
200.65
178.06
176.55
138.07
138.60
Jun-20
C
648.59
706.51
171.99
150.22
149.14
110.83
107.80
Sep-20
C
879.32
888.36
149.77
127.81
126.93
76.47
76.47
Dec-20
C
857.20
871.22
230.06
212.35
211.41
156.51
156.51
Mar-21
C
813.75
843.35
81.49
63.64
63.01
14.33
12.40
Jun-21
C
789.99
821.72
183.40
165.69
164.90
121.08
121.08
Sep-21
C
1009.87
1024.84
291.49
273.89
273.54
204.24
204.24
Dec-21
C
815.92
826.24
190.21
172.34
171.76
150.35
150.35
Mar-22
C
809.63
828.39
223.48
208.13
207.85
1219.05
1219.05
Jun-22
C
745.10
772.71
176.53
160.71
160.03
119.28
119.28
Sep-22
C
916.87
938.84
278.90
262.54
262.15
193.42
193.42
Dec-22
C
802.30
825.72
252.12
235.71
235.62
164.56
164.56
* C - Consolidated, S - Standalone